e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Rehabilitation: more than just exercise
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fat free mass is a major determinant of exercise tolerance in COPD patients
L. Malagrinò, F. Costa, D. Nieri, S. Antonelli, C. De Simone, G. De Cusatis, B. Vagaggini, P. L. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2010 - Rehabilitation: more than just exercise
Session:
Rehabilitation: more than just exercise
Session type:
Thematic Poster Session
Number:
615
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Malagrinò, F. Costa, D. Nieri, S. Antonelli, C. De Simone, G. De Cusatis, B. Vagaggini, P. L. Paggiaro (Pisa, Italy). Fat free mass is a major determinant of exercise tolerance in COPD patients. Eur Respir J 2010; 36: Suppl. 54, 615
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Dyspnoea and fat free mass are major determinants of reduced physical activity in COPD patients
Source: Annual Congress 2011 - Physical activity monitors: from toy to valid tool?
Year: 2011
Whole-body resting and exercise-induced lipolysis in sarcopaenic patients with COPD
Source: Eur Respir J 2008; 32: 1466-1471
Year: 2008
Effects of pulmonary rehabilitation in patients with COPD with and without fat free mass depletion
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Maximal exercise in obese patients with COPD. The role of the fat free mass
Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease
Year: 2014
Influence of body weight and fat mass on pulmonary function and performance status of COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003
The combination of low fat-free mass and high fat mass is related to functional outcome and systemic inflammation in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Impact of fat mass on spirometric parameters and physical exercise tolerance in obese women
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Fat-free mass depletion and functional exercise capacity in COPD patients
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007
Pulmonary rehabilitation and nutritional support in COPD patients with altered body composition and poor exercise capacity
Source: International Congress 2016 – PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease
Year: 2016
Influence of respiratory muscle strength and body weight on exercise metabolism in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 490s
Year: 2001
Mitochondrial dysfunction in COPD patients with low body mass index
Source: Eur Respir J 2007; 30: 600
Year: 2007
Extent of emphysema and low fat free mass in COPD
Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution
Year: 2009
Nutritional state affects central drive and exercise tolerance in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002
Assessment of nutrition and muscle mass loss in patients with severe COPD.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Larger improvements in endurance capacity in fat-free mass depleted COPD patients by non-linear resistance training
Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects
Year: 2011
The relation of body mass index to survival and respiratory function in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 717s
Year: 2005
Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients?
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
d-ETCO2/d-VO2 is a useful index to evaluate exercise tolerance in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Fat free mass index of patients with chronic obstructive pulmonary disease in relation to disease severity quality of life and exercise capacity
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
Exercise tolerance is related to lung density in patients with COPD
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept